GlassScriptPhysician profile
Christopher L Vickery
NPI 1952377228
$1,359.99
in general payments reported to CMS, 2019-2025
14 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $117 · 2021: $102 · 2022: $227 · 2023: $252 · 2024: $149 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.68 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $330.67 | 2022-2023 | Nucala |
| Optinose US, INC. | $236.16 | 2019-2025 | |
| Acclarent, INC | $166.59 | 2019-2023 | Relieva Tract |
| Astrazeneca Pharmaceuticals LP | $140.40 | 2019-2024 | Fasenra |
| Regeneron Healthcare Solutions, INC. | $107.54 | 2022-2024 | Dupixent |
| Jazz Pharmaceuticals INC. | $86.37 | 2019 | |
| Genzyme Corporation | $77.28 | 2025 | |
| Intersect Ent, INC. | $66.04 | 2020 | |
| Kaleo, INC. | $37.88 | 2019-2021 | |
| Amgen INC. | $34.00 | 2025 | |
| Stryker Corporation | $28.41 | 2019 | |
| Medtronic, INC. | $19.09 | 2023 | Stealthstation S8 Platform |
| Tactile Systems Technology INC | $17.50 | 2025 | Nimbl, Flexitouch Plus |
| Genentech USA, INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Vickery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.